Deepak L. Bhatt, MD, MPH, FACC

Deepak L. Bhatt, MD, MPH, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Elsevier Practice Update Cardiology(SIGNIFICANT), Medtelligence/WebMD(SIGNIFICANT), WebMD(SIGNIFICANT), MJH Life Sciences(SIGNIFICANT), Level Ex(SIGNIFICANT), K2P(SIGNIFICANT) OFFICER, DIRECTOR ETC: TobeSoft(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Eisai(SIGNIFICANT), FlowCo(NONE), Roche(SIGNIFICANT), Sanofi Aventis(SIGNIFICANT), Bristol Myers Squibb(SIGNIFICANT), Takeda(NONE), Pfizer Inc(SIGNIFICANT), Forest Laboratories(SIGNIFICANT), Amarin(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Medtronic(SIGNIFICANT), Ethicon(SIGNIFICANT), Ischemix(SIGNIFICANT), The Medicines Company(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Chiesi(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), Ironwood(SIGNIFICANT), Abbott(SIGNIFICANT), Regeneron(SIGNIFICANT), PhaseBio(SIGNIFICANT), Idorsia(SIGNIFICANT), Synaptic(SIGNIFICANT), Novo Nordisk Inc.(NONE), Afimmune(SIGNIFICANT), Fractyl(SIGNIFICANT), PLx Pharma(SIGNIFICANT), Lexicon(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Cardax(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Medscape Cardiology(NONE), Regado Biosciences(NONE), Merck & Co., Inc.(NONE), Elsevier(MODEST), Journal of Invasive Cardiology(SIGNIFICANT), Belvoir Publications(SIGNIFICANT), Clinical Cardiology(NONE), Slack Publications/Cardiology Research Foundation(SIGNIFICANT), HMP Global(SIGNIFICANT), PhaseBio(NONE), Cereno Scientific(NONE), PLx Pharma(NONE), Cardax(NONE)

View Full Disclosure